EU Supply Integrity Guidelines

A summary of strategies pharmaceutical companies can adopt to minimise the negative impact of parallel trade on their business.

In the document, best practices for European distribution and supply integrity management are highlighted as emerged from discussions with Alira Health’s internal experts and industry practitioners.

The documents set out the key components of a successful distribution strategy at the corporate and country level and in the pre-launch phase that pharmaceutical companies should adopt for patent-protected medicines in order to increase the effectiveness and performance of European distribution.

EU Supply Integrity Guidelines

Download “EU Supply Integrity Guidelines” and email [email protected] with any questions. 

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.